Which has stronger valuation & earnings, CERT or WAY?

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.33 -$1.60M -$0.45 N/A Waystar $1.10B 4.65 $112.09M $0.70 38.11

Is CERT or WAY more profitable?

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Waystar 11.18% 7.03% 4.75%

Does the media refer more to CERT or WAY?

In the previous week, Certara had 1 more articles in the media than Waystar. MarketBeat recorded 11 mentions for Certara and 10 mentions for Waystar. Certara's average media sentiment score of 0.69 beat Waystar's score of 0.48 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waystar 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, DOCS or CERT?

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 8.40 $196.05M $0.85 35.74 Certara $418.84M 3.33 -$1.60M -$0.45 N/A

Is DOCS or CERT more profitable?

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% Certara -16.75% 3.86% 2.65%

Does the media favor DOCS or CERT?

In the previous week, Doximity had 18 more articles in the media than Certara. MarketBeat recorded 29 mentions for Doximity and 11 mentions for Certara. Certara's average media sentiment score of 0.69 beat Doximity's score of 0.19 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 3 Very Positive mention(s) 2 Positive mention(s) 23 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Certara 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, CERT or HTFL?

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.33 -$1.60M -$0.45 N/A Heartflow $212.07M 20.39 -$116.79M -$1.83 N/A

Is CERT or HTFL more profitable?

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Heartflow -55.82% -23.52% -18.66%

Does the media prefer CERT or HTFL?

In the previous week, Certara had 6 more articles in the media than Heartflow. MarketBeat recorded 11 mentions for Certara and 5 mentions for Heartflow. Certara's average media sentiment score of 0.69 beat Heartflow's score of 0.26 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, SDGR or CERT?

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 7.87 -$103.26M -$0.74 N/A Certara $418.84M 3.33 -$1.60M -$0.45 N/A

Is SDGR or CERT more profitable?

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Certara -16.75% 3.86% 2.65%

Does the media prefer SDGR or CERT?

In the previous week, Certara had 4 more articles in the media than Schrodinger. MarketBeat recorded 11 mentions for Certara and 7 mentions for Schrodinger. Certara's average media sentiment score of 0.69 beat Schrodinger's score of 0.55 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Certara 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, CERT or GDRX?

GoodRx has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.33 -$1.60M -$0.45 N/A GoodRx $796.85M 1.47 $30.44M $0.04 85.75

Is CERT or GDRX more profitable?

GoodRx has a net margin of 2.07% compared to Certara's net margin of -16.75%. GoodRx's return on equity of 7.22% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% GoodRx 2.07% 7.22% 2.53%

Does the media refer more to CERT or GDRX?

In the previous week, Certara had 9 more articles in the media than GoodRx. MarketBeat recorded 11 mentions for Certara and 2 mentions for GoodRx. Certara's average media sentiment score of 0.69 beat GoodRx's score of 0.14 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Certara (CERT) Competitors

$9.13 +0.49 (+5.67%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$9.14 +0.00 (+0.05%)

As of 10/9/2026 07:53 PM Eastern

Compare

CERT vs. WAY, DOCS, HTFL, SDGR, and GDRX

Should you buy Certara stock or one of its competitors? Certara's main competitors and comparable companies include Waystar (WAY), Doximity (DOCS), Heartflow (HTFL), Schrodinger (SDGR), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Certara compare to Waystar?

Certara (NASDAQ:CERT) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Waystar	11.18%	7.03%	4.75%

74.0% of Certara shares are held by institutional investors. 1.1% of Certara shares are held by company insiders. Comparatively, 3.5% of Waystar shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Certara has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market. Comparatively, Waystar has a beta of 0.18, suggesting that its share price is 82% less volatile than the broader market.

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.33	-$1.60M	-$0.45	N/A
Waystar	$1.10B	4.65	$112.09M	$0.70	38.11

In the previous week, Certara had 1 more articles in the media than Waystar. MarketBeat recorded 11 mentions for Certara and 10 mentions for Waystar. Certara's average media sentiment score of 0.69 beat Waystar's score of 0.48 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waystar	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Certara presently has a consensus price target of $8.60, indicating a potential downside of 5.81%. Waystar has a consensus price target of $34.67, indicating a potential upside of 29.94%. Given Waystar's stronger consensus rating and higher probable upside, analysts clearly believe Waystar is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92

Summary

Waystar beats Certara on 13 of the 17 factors compared between the two stocks.

How does Certara compare to Doximity?

Doximity (NYSE:DOCS) and Certara (NASDAQ:CERT) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Certara	-16.75%	3.86%	2.65%

In the previous week, Doximity had 18 more articles in the media than Certara. MarketBeat recorded 29 mentions for Doximity and 11 mentions for Certara. Certara's average media sentiment score of 0.69 beat Doximity's score of 0.19 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	3 Very Positive mention(s)	2 Positive mention(s)	23 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Certara	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	8.40	$196.05M	$0.85	35.74
Certara	$418.84M	3.33	-$1.60M	-$0.45	N/A

Doximity currently has a consensus target price of $31.95, suggesting a potential upside of 5.18%. Certara has a consensus target price of $8.60, suggesting a potential downside of 5.81%. Given Doximity's higher probable upside, equities analysts plainly believe Doximity is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.24
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Doximity has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, Certara has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market.

87.2% of Doximity shares are held by institutional investors. Comparatively, 74.0% of Certara shares are held by institutional investors. 31.8% of Doximity shares are held by insiders. Comparatively, 1.1% of Certara shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Doximity beats Certara on 13 of the 16 factors compared between the two stocks.

How does Certara compare to Heartflow?

Certara (NASDAQ:CERT) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Certara currently has a consensus target price of $8.60, suggesting a potential downside of 5.81%. Heartflow has a consensus target price of $46.25, suggesting a potential downside of 7.02%. Given Certara's higher possible upside, equities research analysts clearly believe Certara is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 7.7% of Heartflow shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Certara has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Comparatively, Heartflow has a beta of 2.73, indicating that its share price is 173% more volatile than the broader market.

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Heartflow	-55.82%	-23.52%	-18.66%

In the previous week, Certara had 6 more articles in the media than Heartflow. MarketBeat recorded 11 mentions for Certara and 5 mentions for Heartflow. Certara's average media sentiment score of 0.69 beat Heartflow's score of 0.26 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.33	-$1.60M	-$0.45	N/A
Heartflow	$212.07M	20.39	-$116.79M	-$1.83	N/A

Summary

Certara beats Heartflow on 11 of the 16 factors compared between the two stocks.

How does Certara compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	7.87	-$103.26M	-$0.74	N/A
Certara	$418.84M	3.33	-$1.60M	-$0.45	N/A

In the previous week, Certara had 4 more articles in the media than Schrodinger. MarketBeat recorded 11 mentions for Certara and 7 mentions for Schrodinger. Certara's average media sentiment score of 0.69 beat Schrodinger's score of 0.55 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Certara	-16.75%	3.86%	2.65%

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Comparatively, 1.1% of Certara shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Schrodinger has a beta of 1.62, indicating that its stock price is 62% more volatile than the broader market. Comparatively, Certara has a beta of 1.42, indicating that its stock price is 42% more volatile than the broader market.

Schrodinger presently has a consensus target price of $20.80, suggesting a potential downside of 23.75%. Certara has a consensus target price of $8.60, suggesting a potential downside of 5.81%. Given Certara's higher possible upside, analysts plainly believe Certara is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.57
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Summary

Certara beats Schrodinger on 11 of the 16 factors compared between the two stocks.

How does Certara compare to GoodRx?

Certara (NASDAQ:CERT) and GoodRx (NASDAQ:GDRX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, Certara had 9 more articles in the media than GoodRx. MarketBeat recorded 11 mentions for Certara and 2 mentions for GoodRx. Certara's average media sentiment score of 0.69 beat GoodRx's score of 0.14 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Certara has a beta of 1.42, meaning that its stock price is 42% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.69, meaning that its stock price is 69% more volatile than the broader market.

GoodRx has a net margin of 2.07% compared to Certara's net margin of -16.75%. GoodRx's return on equity of 7.22% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
GoodRx	2.07%	7.22%	2.53%

GoodRx has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.33	-$1.60M	-$0.45	N/A
GoodRx	$796.85M	1.47	$30.44M	$0.04	85.75

74.0% of Certara shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 1.1% of Certara shares are held by company insiders. Comparatively, 5.9% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Certara currently has a consensus price target of $8.60, suggesting a potential downside of 5.81%. GoodRx has a consensus price target of $4.23, suggesting a potential upside of 23.24%. Given GoodRx's higher possible upside, analysts plainly believe GoodRx is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

Summary

GoodRx beats Certara on 9 of the 16 factors compared between the two stocks.

Get Certara News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CERT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CERT vs. The Competition

Export

Metric	Certara	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.32B	$1.81B	$7.16B	$13.21B
Dividend Yield	N/A	3.96%	2.53%	16.37%
P/E Ratio	-20.29	21.78	274.15	26.16
Price / Sales	3.33	95.31	635.98	112.53
Price / Cash	11.42	31.98	76.38	53.09
Price / Book	1.37	6.25	11.21	6.34
Net Income	-$1.60M	-$19.09M	$3.50B	$381.90M
7 Day Performance	-2.46%	-0.57%	-0.90%	-1.41%
1 Month Performance	23.05%	1.40%	-4.44%	-3.48%
1 Year Performance	-23.02%	-19.77%	6.96%	1.16%

Certara Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CERT Certara	1.917 of 5 stars	$9.13 +5.7%	$8.60 -5.8%	-29.4%	$1.32B	$418.84M	N/A	1,576	News Coverage Analyst Forecast Options Volume Gap Up
WAY Waystar	4.2298 of 5 stars	$26.48 +6.7%	$34.67 +30.9%	-28.7%	$5.08B	$1.21B	37.83	1,700	News Coverage Insider Trade
DOCS Doximity	3.8946 of 5 stars	$28.69 +2.7%	$31.95 +11.4%	N/A	$4.98B	$644.86M	33.75	880	Trending News Analyst Upgrade
HTFL Heartflow	1.5134 of 5 stars	$52.21 +5.9%	$46.25 -11.4%	+51.2%	$4.29B	$176.03M	N/A	843
SDGR Schrodinger	2.2616 of 5 stars	$32.60 +7.6%	$20.80 -36.2%	+32.1%	$2.24B	$259.04M	N/A	850

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CERT) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Certara (CERT) Competitors